Announced Mon, 10 Aug, 2026 · 15:47 IST
Q1 FY27 results; CFO swap with new WTD-CFO appointment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reactionminutes from the announcement price · days from the prior close
—Next day
₹3.82
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.2%—
Pharmaceuticals peers, median of 165sector-0.4%—
Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
—-0.2—+0.1—
Next day
—+0.2—-0.4—
2d
—+0.4—+0.1—
3d
-5.0+0.4-5.4-0.4-4.5
4d
-9.7+0.6-10.2-0.9-8.8
5d
-9.7+0.9-10.6-0.5-9.2
1w
-5.2+0.9-6.1-1.0-4.3
15d
-9.9+0.9-10.9-0.6-9.4
1m
-1.8+2.3-4.2+1.1-3.0
2m
—-1.1—-3.1—
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending
Minute windows have no benchmark: there is no intraday index history to compare against.
AI summary
Board approved Q1 FY27 unaudited results. Revenue 7.78 lakhs vs 7.16, net profit 0.65 lakhs vs 1.28 (down about 49 percent). Ms. Roshni Poddar appointed as Whole-Time Director and CFO for 5 years. Mr. Swaraj Kumar Singh resigned as CFO same day. 30th AGM on Sep 23 via video conference.
Likely market impact
Simultaneous CFO exit and entry plus 49 percent profit drop raise governance questions for retail investors.